Thursday, October 3 • 11:00am - 11:20am
AI in Drug Discovery Today- Machine Learning Models for High Throughput Microscopy Screening and Large Scale Liability Prediction

Sign up or log in to save this to your schedule and see who's attending!

AI in Drug Discovery Today:
AI has become a useful tool that can help with the complexity and scale of biology. This track will introduce current uses of AI and machine learning in drug discovery. Experienced speakers will present their work and how they use AI in the context of therapeutic research: different methods can assist answering diverse and complex questions or optimizing everyday research.

Machine Learning Models for High Throughput Microscopy Screening and Large Scale Liability Prediction
As Recursion, we combine AI with large-scale lab automation to discover new medical treatments. Using our automated, high throughput screening (HTS) platform, we run hundreds of thousands of mini-experiments spanning millions of microscopy images - every single week. In this talk, we’ll describe how we use machine learning analytics to make sense of all of this complex data - that is, to identify promising drug compounds while simultaneously avoiding high risk ones. This process relies on sophisticated model development, but also on engineering infrastructure that can handle petabytes of data, as well as on optimizing our HTS experiments to best enable downstream machine learning tasks. Finally, we will show how we are building on our HTS discovery platform to gain deeper insights about drug compounds of interest, for example through by applying generative machine learning models to predict likely downstream liabilities, such as heart and liver toxicities.


Lina Nilsson

Senior Director, Data Science Product, Recursion
Lina Nilsson is Senior Director of Data Science Product at Recursion Pharmaceuticals, a company that is reimagining drug discovery through machine learning and large-scale experiment automation. Previously, she was the COO of Enlitic, a startup that uses deep learning to improve clinical... Read More →

avatar for Yohann Potier, Ph.D.

Yohann Potier, Ph.D.

Director of Data Science & Informatics, Voyager Therapeutics
Yohann was recently named Director of Data Science & Informatics at Voyager Therapeutics, after almost six years at the Novartis Institute for Biomedical Research. He studied Biotechnology and Informatics in France followed by a Ph.D. in Computational Chemistry at the University of... Read More →

Thursday October 3, 2019 11:00am - 11:20am
Theater Ballroom (5th Fl) - Courtyard Boston Downtown 275 Tremont Street, Boston, MA 02116

Attendees (1)